These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae. Kim SN, Jeong HS, Park SN, Kim HJ. J Virol Methods; 2007 Jan; 139(1):24-30. PubMed ID: 17034867 [Abstract] [Full Text] [Related]
27. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris. Sanchooli A, Aghaiypour K, Kiasari BA, Samarbaf-Zadeh A, Ghadiri A, Makvandi M. Protein Pept Lett; 2018 Jan; 25(8):783-790. PubMed ID: 30091403 [Abstract] [Full Text] [Related]
31. Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen. Diamos AG, Larios D, Brown L, Kilbourne J, Kim HS, Saxena D, Palmer KE, Mason HS. Vaccine; 2019 Jan 03; 37(1):137-144. PubMed ID: 30459071 [Abstract] [Full Text] [Related]
32. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine. Hassan SW, Waheed MT, Müller M, Clarke JL, Shinwari ZK, Lössl AG. Hum Vaccin Immunother; 2014 Jan 03; 10(10):2975-82. PubMed ID: 25483463 [Abstract] [Full Text] [Related]
39. HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice. Berg M, Gambhira R, Siracusa M, Hoiczyk E, Roden R, Ketner G. Vaccine; 2007 Apr 30; 25(17):3501-10. PubMed ID: 16914239 [Abstract] [Full Text] [Related]
40. Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles. Patel MC, Patkar KK, Basu A, Mohandas KM, Mukhopadhyaya R. Indian J Med Res; 2009 Sep 30; 130(3):213-8. PubMed ID: 19901429 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]